HEM Chart by TradingView

Business Description

At Hemostemix, we believe healthcare should be personal. We believe our bodies can be the source of our own therapies. And we believe that we can shape the future of medicine by delivering regenerative medicines that are safe and effective.

Website https://hemostemix.com/

FRC Analyst's Reports

Hemostemix Inc. (TSXV: HEM / OTC: HMTXF) – Awaiting Results of Phase II Trials of a Potential Therapy for Cardiovascular Diseases – Initiating Coverage Aug. 24, 2022


Hemostemix Announces A Clarification Aug. 31, 2022
Hemostemix Announces Phase II Results Plus New Heart Study Demonstrating Statistically Significant Improvement in Ejection Fraction at 4 and 12 Months after ACP-01 Heart Injections Aug. 30, 2022

This company was mentioned in the following "Analysts’ Ideas Of The Week":